Evolocumab Does Not Impact Cognition in Atherosclerotic CVD
Adding evolocumab to maximally tolerated statin therapy did not affect patient-reported cognition
SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors
April 2020 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2020. This roundup includes the latest...
FDA Issues Emergency Use Authorization for Remdesivir
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Symptomatic Health Care Staff in U.K. Screened for COVID-19
Shift in transmission dynamics noted as of March 24, concurrent with steps to implement social distancing
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
Psoriasis Tied to Higher Alzheimer Disease Risk
Among psoriasis patients, those on systemic treatment had lower risk for Alzheimer disease
Choice of Spinal Anesthesia Key to Early Ambulation After THA
Patients who received mepivacaine rather than bupivacaine more likely to ambulate at 3.5 hours
PFS Prolonged With Continuous Dabrafenib, Trametinib in Melanoma
Median PFS longer with continuous versus intermittent treatment, but overall survival similar
